Intravenous dexamethasone pretreatment reduces fentanyl-induced cough

Jui A. Lin, Fa Chang Chen, Meei Shyuan Lee, Huei C. Horng, Chen Hwan Cherng, Chun Chang Yeh, Chih Shung Wong

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background/Purpose: Fentanyl is regularly used in clinical anesthesia practice but fentanyl-induced cough (FIC) will sometimes bother anesthesiologists. This study was designed to examine the effect of intravenous (IV) dexamethasone (DEX) on FIC. Methods: Eighty ASA class I-II patients, aged 18-80 years and weighing 40-90 kg, scheduled for elective surgery were given DEX to reduce FIC. One hundred and eight patients from our previous study database on FIC, after excluding smokers, comprised the reference group. All patients were given fentanyl (100 μg for 40-69 kg and 150 pg for 70-90 kg for clinical convenience) over 2 seconds via the proximal port of a peripheral IV line in the forearm. Patients in the treatment group received DEX (10 mg, IV) 5 minutes prior to fentanyl injection, while those in the reference group received fentanyl injection only without any premedicant. We recorded the number of coughs of each patient for 30 seconds after fentanyl injection. Results: The incidence of cough was 6.3% in the DEX group and 21.3% in the control group, respectively (p = 0.008). However, the severity of cough observed was not significantly different by DEX pretreatment (p > 0.05) or hemodynamic profiles. Conclusion: DEX (10 mg, IV) 5 minutes prior to fentanyl injection reduces the incidence of FIC and can be an ideal premedicant for general anesthesia induction.

Original languageEnglish
Pages (from-to)649-655
Number of pages7
JournalJournal of the Formosan Medical Association = Taiwan yi zhi
Volume106
Issue number8
DOIs
Publication statusPublished - Aug 2007
Externally publishedYes

Fingerprint

Fentanyl
Cough
Dexamethasone
Injections
Incidence
Forearm
General Anesthesia
Anesthesia
Hemodynamics
Databases
Control Groups

Keywords

  • Cough
  • Dexamethasone
  • Fentanyl

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Intravenous dexamethasone pretreatment reduces fentanyl-induced cough. / Lin, Jui A.; Chen, Fa Chang; Lee, Meei Shyuan; Horng, Huei C.; Cherng, Chen Hwan; Yeh, Chun Chang; Wong, Chih Shung.

In: Journal of the Formosan Medical Association = Taiwan yi zhi, Vol. 106, No. 8, 08.2007, p. 649-655.

Research output: Contribution to journalArticle

Lin, Jui A. ; Chen, Fa Chang ; Lee, Meei Shyuan ; Horng, Huei C. ; Cherng, Chen Hwan ; Yeh, Chun Chang ; Wong, Chih Shung. / Intravenous dexamethasone pretreatment reduces fentanyl-induced cough. In: Journal of the Formosan Medical Association = Taiwan yi zhi. 2007 ; Vol. 106, No. 8. pp. 649-655.
@article{2ffe46da16664670803a80753a95ac7f,
title = "Intravenous dexamethasone pretreatment reduces fentanyl-induced cough",
abstract = "Background/Purpose: Fentanyl is regularly used in clinical anesthesia practice but fentanyl-induced cough (FIC) will sometimes bother anesthesiologists. This study was designed to examine the effect of intravenous (IV) dexamethasone (DEX) on FIC. Methods: Eighty ASA class I-II patients, aged 18-80 years and weighing 40-90 kg, scheduled for elective surgery were given DEX to reduce FIC. One hundred and eight patients from our previous study database on FIC, after excluding smokers, comprised the reference group. All patients were given fentanyl (100 μg for 40-69 kg and 150 pg for 70-90 kg for clinical convenience) over 2 seconds via the proximal port of a peripheral IV line in the forearm. Patients in the treatment group received DEX (10 mg, IV) 5 minutes prior to fentanyl injection, while those in the reference group received fentanyl injection only without any premedicant. We recorded the number of coughs of each patient for 30 seconds after fentanyl injection. Results: The incidence of cough was 6.3{\%} in the DEX group and 21.3{\%} in the control group, respectively (p = 0.008). However, the severity of cough observed was not significantly different by DEX pretreatment (p > 0.05) or hemodynamic profiles. Conclusion: DEX (10 mg, IV) 5 minutes prior to fentanyl injection reduces the incidence of FIC and can be an ideal premedicant for general anesthesia induction.",
keywords = "Cough, Dexamethasone, Fentanyl",
author = "Lin, {Jui A.} and Chen, {Fa Chang} and Lee, {Meei Shyuan} and Horng, {Huei C.} and Cherng, {Chen Hwan} and Yeh, {Chun Chang} and Wong, {Chih Shung}",
year = "2007",
month = "8",
doi = "10.1016/S0929-6646(08)60022-4",
language = "English",
volume = "106",
pages = "649--655",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Elsevier Science Publishers B.V.",
number = "8",

}

TY - JOUR

T1 - Intravenous dexamethasone pretreatment reduces fentanyl-induced cough

AU - Lin, Jui A.

AU - Chen, Fa Chang

AU - Lee, Meei Shyuan

AU - Horng, Huei C.

AU - Cherng, Chen Hwan

AU - Yeh, Chun Chang

AU - Wong, Chih Shung

PY - 2007/8

Y1 - 2007/8

N2 - Background/Purpose: Fentanyl is regularly used in clinical anesthesia practice but fentanyl-induced cough (FIC) will sometimes bother anesthesiologists. This study was designed to examine the effect of intravenous (IV) dexamethasone (DEX) on FIC. Methods: Eighty ASA class I-II patients, aged 18-80 years and weighing 40-90 kg, scheduled for elective surgery were given DEX to reduce FIC. One hundred and eight patients from our previous study database on FIC, after excluding smokers, comprised the reference group. All patients were given fentanyl (100 μg for 40-69 kg and 150 pg for 70-90 kg for clinical convenience) over 2 seconds via the proximal port of a peripheral IV line in the forearm. Patients in the treatment group received DEX (10 mg, IV) 5 minutes prior to fentanyl injection, while those in the reference group received fentanyl injection only without any premedicant. We recorded the number of coughs of each patient for 30 seconds after fentanyl injection. Results: The incidence of cough was 6.3% in the DEX group and 21.3% in the control group, respectively (p = 0.008). However, the severity of cough observed was not significantly different by DEX pretreatment (p > 0.05) or hemodynamic profiles. Conclusion: DEX (10 mg, IV) 5 minutes prior to fentanyl injection reduces the incidence of FIC and can be an ideal premedicant for general anesthesia induction.

AB - Background/Purpose: Fentanyl is regularly used in clinical anesthesia practice but fentanyl-induced cough (FIC) will sometimes bother anesthesiologists. This study was designed to examine the effect of intravenous (IV) dexamethasone (DEX) on FIC. Methods: Eighty ASA class I-II patients, aged 18-80 years and weighing 40-90 kg, scheduled for elective surgery were given DEX to reduce FIC. One hundred and eight patients from our previous study database on FIC, after excluding smokers, comprised the reference group. All patients were given fentanyl (100 μg for 40-69 kg and 150 pg for 70-90 kg for clinical convenience) over 2 seconds via the proximal port of a peripheral IV line in the forearm. Patients in the treatment group received DEX (10 mg, IV) 5 minutes prior to fentanyl injection, while those in the reference group received fentanyl injection only without any premedicant. We recorded the number of coughs of each patient for 30 seconds after fentanyl injection. Results: The incidence of cough was 6.3% in the DEX group and 21.3% in the control group, respectively (p = 0.008). However, the severity of cough observed was not significantly different by DEX pretreatment (p > 0.05) or hemodynamic profiles. Conclusion: DEX (10 mg, IV) 5 minutes prior to fentanyl injection reduces the incidence of FIC and can be an ideal premedicant for general anesthesia induction.

KW - Cough

KW - Dexamethasone

KW - Fentanyl

UR - http://www.scopus.com/inward/record.url?scp=34548505051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548505051&partnerID=8YFLogxK

U2 - 10.1016/S0929-6646(08)60022-4

DO - 10.1016/S0929-6646(08)60022-4

M3 - Article

VL - 106

SP - 649

EP - 655

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

IS - 8

ER -